![Elizabeth Ingram](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Ingram
Vorstandsvorsitzender bei
Cipla Therapeutics, Inc.
Profil
Elizabeth G.
Ingram is President & Chief Executive Officer at Cipla Therapeutics, Inc. and serves on the Board of Sanofi Ventures LLC.
Former roles include Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022, Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014, Chief Marketing Officer at MannKind Corp.
from 2018 to 2019, and Senior Vice President-Managed Market at DexCom, Inc. in 2017.
Education includes undergraduate studies at East Carolina University and graduate studies at the University of South Carolina.
Aktive Positionen von Elizabeth Ingram
| Unternehmen | Position | Beginn |
|---|---|---|
Cipla Therapeutics, Inc. | Vorstandsvorsitzender | - |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Elizabeth Ingram
| Unternehmen | Position | Ende |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.10.2022 |
| MANNKIND CORPORATION | Vertrieb & Marketing | 01.06.2019 |
| DEXCOM, INC. | Corporate Officer/Principal | 01.12.2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Elizabeth Ingram
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MannKind Corp.
 MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
East Carolina University
 East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Cipla Therapeutics, Inc. |
